393 related articles for article (PubMed ID: 25595909)
1. Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.
Rybak AP; Bristow RG; Kapoor A
Oncotarget; 2015 Feb; 6(4):1900-19. PubMed ID: 25595909
[TBL] [Abstract][Full Text] [Related]
2. Gene signatures distinguish stage-specific prostate cancer stem cells isolated from transgenic adenocarcinoma of the mouse prostate lesions and predict the malignancy of human tumors.
Mazzoleni S; Jachetti E; Morosini S; Grioni M; Piras IS; Pala M; Bulfone A; Freschi M; Bellone M; Galli R
Stem Cells Transl Med; 2013 Sep; 2(9):678-89. PubMed ID: 23884639
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
4. Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.
Wang Z; Wu D; Ng CF; Teoh JY; Yu S; Wang Y; Chan FL
Endocr Relat Cancer; 2018 Jan; 25(1):35-50. PubMed ID: 29042395
[TBL] [Abstract][Full Text] [Related]
5. Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells.
Gao W; Wang Y; Yu S; Wang Z; Ma T; Chan AM; Chiu PK; Ng CF; Wu D; Chan FL
Stem Cell Res Ther; 2022 May; 13(1):188. PubMed ID: 35526071
[TBL] [Abstract][Full Text] [Related]
6. SOX2 plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells.
Rybak AP; Tang D
Cell Signal; 2013 Dec; 25(12):2734-42. PubMed ID: 24036214
[TBL] [Abstract][Full Text] [Related]
7. Patterns of stemness-associated markers in the development of castration-resistant prostate cancer.
Federer-Gsponer JR; Müller DC; Zellweger T; Eggimann M; Marston K; Ruiz C; Seifert HH; Rentsch CA; Bubendorf L; Le Magnen C
Prostate; 2020 Sep; 80(13):1108-1117. PubMed ID: 32628318
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of FAM84B during prostate cancer progression.
Wong N; Gu Y; Kapoor A; Lin X; Ojo D; Wei F; Yan J; de Melo J; Major P; Wood G; Aziz T; Cutz JC; Bonert M; Patterson AJ; Tang D
Oncotarget; 2017 Mar; 8(12):19218-19235. PubMed ID: 28186973
[TBL] [Abstract][Full Text] [Related]
9. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
10. Androgen receptor and prostate cancer stem cells: biological mechanisms and clinical implications.
Deng Q; Tang DG
Endocr Relat Cancer; 2015 Dec; 22(6):T209-20. PubMed ID: 26285606
[TBL] [Abstract][Full Text] [Related]
11. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer.
Yun EJ; Zhou J; Lin CJ; Hernandez E; Fazli L; Gleave M; Hsieh JT
Clin Cancer Res; 2016 Feb; 22(3):670-9. PubMed ID: 26490309
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
[TBL] [Abstract][Full Text] [Related]
13. β4 Integrin signaling induces expansion of prostate tumor progenitors.
Yoshioka T; Otero J; Chen Y; Kim YM; Koutcher JA; Satagopan J; Reuter V; Carver B; de Stanchina E; Enomoto K; Greenberg NM; Scardino PT; Scher HI; Sawyers CL; Giancotti FG
J Clin Invest; 2013 Feb; 123(2):682-99. PubMed ID: 23348745
[TBL] [Abstract][Full Text] [Related]
14. New insights into prostate cancer stem cells.
Chen X; Rycaj K; Liu X; Tang DG
Cell Cycle; 2013 Feb; 12(4):579-86. PubMed ID: 23370446
[TBL] [Abstract][Full Text] [Related]
15. [Prostate cancer stem cells: advances in current research].
Wu G; Wu DL
Zhonghua Nan Ke Xue; 2015 Feb; 21(2):170-4. PubMed ID: 25796694
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells.
Jiao J; Hindoyan A; Wang S; Tran LM; Goldstein AS; Lawson D; Chen D; Li Y; Guo C; Zhang B; Fazli L; Gleave M; Witte ON; Garraway IP; Wu H
PLoS One; 2012; 7(8):e42564. PubMed ID: 22880034
[TBL] [Abstract][Full Text] [Related]
17. Transient receptor potential melastatin 4 channel contributes to migration of androgen-insensitive prostate cancer cells.
Holzmann C; Kappel S; Kilch T; Jochum MM; Urban SK; Jung V; Stöckle M; Rother K; Greiner M; Peinelt C
Oncotarget; 2015 Dec; 6(39):41783-93. PubMed ID: 26496025
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer stem-like cells proliferate slowly and resist etoposide-induced cytotoxicity via enhancing DNA damage response.
Yan J; Tang D
Exp Cell Res; 2014 Oct; 328(1):132-142. PubMed ID: 25149681
[TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Stem Cells: Research Advances.
Jaworska D; Król W; Szliszka E
Int J Mol Sci; 2015 Nov; 16(11):27433-49. PubMed ID: 26593898
[TBL] [Abstract][Full Text] [Related]
20. Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells.
Rybak AP; He L; Kapoor A; Cutz JC; Tang D
Biochim Biophys Acta; 2011 May; 1813(5):683-94. PubMed ID: 21277911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
